How one scientist defied the medical consensus to link viruses to cervical cancer
In short: For years, the medical establishment was convinced that herpesviruses caused cervical cancer. Harald zur Hausen disagreed. By betting on a different, overlooked suspect—the human papillomavirus—he faced intense scientific skepticism. His persistence eventually led to a Nobel Prize and a vaccine that now prevents hundreds of thousands of cancer cases annually.
Born in 1936, Harald zur Hausen’s early education was disrupted by the Second World War, yet he remained determined to pursue science. After graduating in medicine in 1960, he eventually moved to the United States to work at the Children’s Hospital of Philadelphia. There, he gained critical experience in virology, specifically working with the Epstein-Barr virus (EBV). His work in the late 1960s provided the first experimental proof that latent viral DNA could persist in human tumor cells, a discovery that fundamentally changed the understanding of how viruses might contribute to malignancy.
In 1972, zur Hausen became chair of the Institute of Clinical Virology in Erlangen-Nürnberg, where he turned his attention to cervical cancer. At the time, the prevailing theory was that Herpes simplex type 2 (HSV-2) was the culprit. However, when zur Hausen’s team failed to find HSV-2 genomes in cervical cancer biopsies, he pivoted to investigate human papillomaviruses (HPVs). This was a controversial shift; his hypothesis faced significant scientific criticism when first published. He and his colleagues eventually isolated HPV-16 and HPV-18 from cervical tumors in 1983 and 1984, proving that these specific strains were the primary drivers of the disease.
The mechanism is now well understood: high-risk HPV strains integrate their DNA into the host cell genome. The viral proteins E6 and E7 then bind to and block the host’s tumor suppressor proteins, p53 and RB, effectively hijacking the cell’s growth machinery. This discovery paved the way for the development of the HPV vaccine, first approved in 2006. Today, the vaccine is a cornerstone of global public health, with over 100 countries incorporating it into immunization programs to work toward the eradication of cervical cancer, a disease that accounts for about 700,000 cancer cases worldwide each year.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Nobel Prize in Physiology or Medicine 2008
- Also: Harald zur Hausen | Nobel Prize, HPV Research, Cancer Prevention | Britannica
- Also: Harald zur Hausen, virologist who linked viruses to cancer (1936–2023)
- Also: Harald zur Hausen
To cite this card, link to https://intellectplus.co.uk/app/health-harald-zur-hausen.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Medicine · More in Health · Latest · A–Z · All topics
